Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

Clinical trial NCT05970679 · COMPLETED

Trial details

NCT number: NCT05970679
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia, Dyslipidemia

Start date: 2022-08-17
Primary completion: 2023-04-13
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.